Pervasis is a clinical stage company developing breakthrough therapies with the potential to improve outcomes following vascular procedures. Learn more
Our therapies build on the ability of the body's endothelium to regulate natural healing processes. Learn more
February 1, 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel ® [PDF]
January 26, 2010
Phacilitate 2010 - Qualification of Raw Materials, Impact of Legacy Materials presentation from Jack Harvey, Director of Manufacturing, Pervasis